A detailed history of Paragon Advisors, LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Paragon Advisors, LLC holds 31,399 shares of RXST stock, worth $1.41 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
31,399
Previous 30,464 3.07%
Holding current value
$1.41 Million
Previous $1.83 Million 15.33%
% of portfolio
0.57%
Previous 0.74%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$40.78 - $57.04 $38,129 - $53,332
935 Added 3.07%
31,399 $1.55 Million
Q2 2024

Aug 13, 2024

BUY
$50.42 - $64.29 $1.54 Million - $1.96 Million
30,464 New
30,464 $1.83 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.24B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Paragon Advisors, LLC Portfolio

Follow Paragon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Advisors, LLC with notifications on news.